Early Diagnosis of Cognitive Impairment in Chronic Cerebral Ischemia
DOI:
https://doi.org/10.51699/cajmns.v7i2.3168Keywords:
Chronic Cerebral Ischemia, Cognitive Impairment, Early Diagnosis, Vascular Cognitive Impairment, Neuropsychological Assessment, Cerebral Circulation DisordersAbstract
Chronic cerebral ischemia is considered to be one of the most widespread cerebrovascular disorders and is often accompanied by the progressive deterioration of cognitive abilities. Early diagnosis of cognitive impairment is vital in preventing the subsequent neurological decline and enhancing the outcome of patients. The current research sought to determine the significance of early diagnostic methods of detecting cognitive impairment in chronically cerebral ischemic patients. The study was carried out at the Republican Scientific and Practical Centre of Sports Medicine and involved 64 patients, who had undergone clinical neurological examination and cognitive appraisal. Standardised neuropsychological screening measures were used to assess cognition, such as the Mini-Mental State Examination and the Montreal Cognitive Assessment. They were able to identify some early cognitive disturbances in memory, attention, and executive functioning. It was also using instrumental diagnostic methods to assess structural and vascular features of the chronic cerebral hypoperfusion. The findings showed that mild impaired mental systems were the most prevalent findings among the patients who were reviewed. A lot of people had developed premature signs of diminished focus, reduced information processing, as well as slight memory disturbances. These results indicate that cognitive deterioration can occur slowly in the initial phases of chronic cerebral ischemia and can go undiagnosed unless cognitive evaluation is performed specifically. The paper states the necessity of a combination of neurological examination, neuropsychological testing, and instrumental diagnostic techniques to identify cognitive impairment in its early stages. Timely preventive and therapeutic methods that can be done early in the progression of cerebrovascular pathology can be done, with early diagnosis, and thus prevent or at least delay the deterioration of cognitive function.
References
Iadecola C, Duering M, Hachinski V, et al. Vascular cognitive impairment and dementia: JACC scientific expert panel. Journal of the American College of Cardiology. 2019;73(25):3326–3344. DOI: 10.1016/j.jacc.2019.04.034
Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurology. 2019;18(7):684–696. DOI: 10.1016/S1474-4422(19)30079-1
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia. Stroke. 2011;42(9):2672–2713. DOI: 10.1161/STR.0b013e3182299496
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment (MoCA). Journal of the American Geriatrics Society. 2005;53(4):695–699. DOI: 10.1111/j.1532-5415.2005.53221.x
Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain MRI. BMJ. 2010;341:c3666. DOI: 10.1136/bmj.c3666
Skrobot OA, O’Brien JT, Black S, et al. Progress toward standardized diagnosis of vascular cognitive impairment. International Journal of Stroke. 2020.
DOI: 10.1177/1747493019900025
Pinto TCC, Machado L, Bulgacov TM, et al. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE)? Dementia & Neuropsychologia. 2019.
DOI: 10.1590/1980-57642018dn13-040003
Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: A clinical review. Neurology. 2019.
DOI: 10.1212/WNL.0000000000007654
Ihara M, Washida K. Linking atrial fibrillation with Alzheimer’s disease: epidemiology, pathology, and mechanisms. Journal of Alzheimer's Disease. 2018.
DOI: 10.3233/JAD-180215
Dichgans M, Leys D. Vascular cognitive impairment. Circulation Research. 2017;120(3):573–591. DOI: 10.1161/CIRCRESAHA.116.308426
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease. Lancet Neurology. 2013;12(8):822–838. DOI: 10.1016/S1474-4422(13)70124-8
Pantoni L. Cerebral small vessel disease: from pathogenesis to clinical characteristics and treatment. Lancet Neurology. 2010;9(7):689–701. DOI: 10.1016/S1474-4422(10)70104-6
Sachdev PS, Lo JW, Crawford JD, et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v2). Lancet Neurology. 2023.
DOI: 10.1016/S1474-4422(23)00117-9
Carson N, Leach L, Murphy KJ. A re-examination of Montreal Cognitive Assessment in vascular cognitive impairment. Clinical Neuropsychologist. 2018.
DOI: 10.1080/13854046.2017.1413213
Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: a clinical review. Neurology. 2019.
DOI: 10.1212/WNL.0000000000007654
Iadecola C. The pathobiology of vascular dementia. Neuron. 2013.
DOI: 10.1016/j.neuron.2013.10.008
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care. Lancet. 2020.
DOI: 10.1016/S0140-6736(20)30367-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Inogamova Nigora Abdulkhayevna

This work is licensed under a Creative Commons Attribution 4.0 International License.


